1. Home
  2. KPTI vs OPP Comparison

KPTI vs OPP Comparison

Compare KPTI & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.94

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

OPP

RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

HOLD

Current Price

$7.88

Market Cap

187.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
OPP
Founded
2008
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
187.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
KPTI
OPP
Price
$8.94
$7.88
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
85.7K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
14.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.65
$7.49
52 Week High
$10.99
$8.77

Technical Indicators

Market Signals
Indicator
KPTI
OPP
Relative Strength Index (RSI) 65.69 62.92
Support Level $5.84 $7.83
Resistance Level $9.00 $8.00
Average True Range (ATR) 0.64 0.13
MACD 0.30 0.03
Stochastic Oscillator 99.72 89.87

Price Performance

Historical Comparison
KPTI
OPP

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: